AWM
TNDM icon

Apollon Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Apollon Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$202K Sell
10,534
-424
-4% -$9.21K ﹤0.01% 1320
2025
Q4 		$241K Sell
10,958
-299
-3% -$5.4K ﹤0.01% 1159
2025
Q3 		$137K Sell
11,257
-109
-1% -$1.48K ﹤0.01% 1254
2025
Q2 		$212K Buy
11,366
+292
+3% +$5.78K ﹤0.01% 1152
2025
Q1 		$212K Sell
11,074
-3,738
-25% -$109K ﹤0.01% 1084
2024
Q4 		$534K Sell
14,812
-719
-5% -$24.3K 0.01% 730
2024
Q3 		$659K Sell
15,531
-318
-2% -$13.5K 0.02% 622
2024
Q2 		$639K Hold
15,849
– – 0.02% 594
2024
Q1 		$561K Sell
15,849
-1,227
-7% -$32.9K 0.02% 653
2023
Q4 		$505K Sell
17,076
-74
-0.4% -$1.53K 0.02% 646
2023
Q3 		$356K Buy
17,150
+8
+0% +$220 0.02% 645
2023
Q2 		$421K Sell
17,142
-2,286
-12% -$73.5K 0.02% 649
2023
Q1 		$789K Sell
19,428
-141
-0.7% -$5.84K 0.05% 393
2022
Q4 		$880K Sell
19,569
-1,205
-6% -$54.5K 0.06% 342
2022
Q3 		$994K Buy
20,774
+108
+0.5% +$5.92K 0.08% 251
2022
Q2 		$1.22M Sell
20,666
-605
-3% -$49.7K 0.1% 221
2022
Q1 		$2.47M Buy
+21,271
New +$2.48M 0.18% 125

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Apollon Wealth Management's TNDM Position: Q1 2026 in Review

Apollon Wealth Management reduced its Tandem Diabetes Care (TNDM) stake by 3.9% in Q1 2026, selling an estimated $9.21K and leaving 10,534 shares worth $202K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Apollon Wealth Management first reported a position in TNDM in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.47M in Q1 2022. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Apollon Wealth Management held 10,534 shares of Tandem Diabetes Care worth $202K as of Q1 2026.
  • Apollon Wealth Management sold 424 Tandem Diabetes Care shares in Q1 2026, an estimated $9.21K.
  • Tandem Diabetes Care made up ﹤0.01% of Apollon Wealth Management's portfolio in Q1 2026, its #1320 holding.
  • Apollon Wealth Management first reported a position in Tandem Diabetes Care in Q1 2022 and has held it in 17 quarters since.
  • Apollon Wealth Management's Tandem Diabetes Care position peaked at $2.47M in Q1 2022.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Apollon Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.